U.S. Interventional Cardiology And Peripheral Market Size, Share & Trends Analysis Report By Product (Interventional Catheters, Microcatheters, Peripheral Stents), By Application (Angioplasty, Congenital Heart Defect Correction), And Segment Forecasts, 2025 - 2030

May 2025 | 160 pages | ID: U483F6789BEAEN
Grand View Research, Inc.

Abstracts

This report can be delivered to the clients within 2 Business Days

U.S. Interventional Cardiology and Peripheral Market Growth & Trends

The U.S. interventional cardiology and peripheral market size is anticipated to reach USD 11.19 billion by 2030, growing at a CAGR of 6.0% during the forecast period, according to a new report by Grand View Research, Inc. The market is driven by the growing burden of cardiovascular & peripheral vascular diseases, rising preference for minimally invasive procedures, and continuous advancements in device technology. Increasing geriatric population, higher rates of diabetes & hypertension, and supportive reimbursement policies further fuel market expansion.

The increasing incidence of cardiovascular conditions contributes to sustained growth in the interventional cardiology and peripheral market. A wide range of patients are being diagnosed with coronary and peripheral arterial blockages at various stages, prompting timely medical intervention. As disease detection improves through diagnostic advancements and routine check-ups, there is greater emphasis on early and less invasive treatment pathways.

Interventional procedures such as angioplasty, stenting, and thrombectomy are now central to managing these conditions effectively. In October 2024, the CDC reported that heart disease remained the leading cause of death in the U.S., responsible for 702,880 deaths in 2022, equivalent to one in every five deaths. Coronary artery disease (CAD) was the most common form, killing over 371,000 people. Risk factors such as high blood pressure, high cholesterol, smoking, diabetes, obesity, and physical inactivity were identified as major contributors.

U.S. Interventional Cardiology And Peripheral Market Report Highlights

• Based on product, the coronary stents segment accounted for the largest revenue share of 41.5% in 2024.
• The segment growth is driven by increasing adoption of Percutaneous Coronary Interventions (PCI), continuous advancements in drug-eluting stent technologies, and favorable reimbursement policies supporting minimally invasive cardiovascular procedures in the U.S.
• Based on application, the angioplasty segment accounted for the largest revenue share of 59.2% in 2024. The significant growth of this segment is largely driven by the high prevalence of atherosclerotic cardiovascular disease, increasing use of drug-eluting balloons & stents, and rising demand for minimally invasive revascularization procedures.
• Emerging players are adopting diverse strategies, such as new product launches, to strengthen their market presence.
• In February 2024, Biotronik launched the Micro Rx catheter in the U.S. to support guidewire procedures during PCI, reflecting ongoing technological progress and sustained market growth.

Companies Mentioned

B. Braun SE
BD
Cardinal Health
Medtronic
Teleflex Incorporated
W. L. Gore & Associates Inc.
Cook
Boston Scientific Corporation
AngioDynamics
Abbott
OrbusNeich Medical Group Holdings Limited

Contents

CHAPTER 1. METHODOLOGY AND SCOPE

1.1. Market Segmentation & Scope
1.2. Segment Definitions
  1.2.1. Product
  1.2.2. Application
  1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
  1.4.1. Purchased database
  1.4.2. GVR’s internal database
  1.4.3. Secondary sources
  1.4.4. Primary research
  1.4.5. Details of primary research
1.5. Information or Data Analysis
  1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Market Outlook
2.2. Segment Outlook
  2.2.1. Product outlook
  2.2.2. Application outlook
2.3. Competitive Insights

CHAPTER 3. U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL MARKET VARIABLES, TRENDS & SCOPE

3.1. Market Lineage Outlook
  3.1.1. Parent market outlook
  3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
  3.2.1. Market driver analysis
  3.2.2. Market restraint analysis
3.3. U.S. Interventional Cardiology and Peripheral Market Analysis Tools
  3.3.1. Industry Analysis - Porter’s
    3.3.1.1. Supplier power
    3.3.1.2. Buyer power
    3.3.1.3. Substitution threat
    3.3.1.4. Threat of new entrants
    3.3.1.5. Competitive rivalry
  3.3.2. PESTEL Analysis
    3.3.2.1. Political landscape
    3.3.2.2. Technological landscape
    3.3.2.3. Economic landscape

CHAPTER 4. U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL MARKET: PRODUCT ESTIMATES & TREND ANALYSIS

4.1. Product Segment Dashboard
4.2. U.S. Interventional Cardiology and Peripheral Market: Product Movement Analysis
4.3. U.S. Interventional Cardiology and Peripheral Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Interventional Catheters
  4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Microcatheters
  4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  4.5.2. Support Microcatheters
    4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  4.5.3. Delivery Microcatheters
    4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  4.5.4. Others
    4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Guidewires
  4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Peripheral Stents
  4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  4.7.2. Self-Expanding
    4.7.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  4.7.3. Balloon-Expandable
    4.7.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  4.7.4. Drug-Eluting Stents
    4.7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Coronary Stents
  4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  4.8.2. Bioabsorbable Stents
    4.8.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  4.8.3. Drug Eluting Stents
    4.8.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  4.8.4. Bare Metal Stents
    4.8.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.9. PTCA Balloon Catheters
  4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.10. Atherectomy Devices
  4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.11. Chronic Total Occlusion Devices
  4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.12. Synthetic Surgical Grafts
  4.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.13. Embolic Protection Devices
  4.13.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.14. IVC Filters
  4.14.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.15. PTA Balloon Catheters
  4.15.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.16. Thrombectomy Devices
  4.16.1. Market estimates and forecasts 2018 to 2030 (USD Million)

CHAPTER 5. U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL MARKET: APPLICATION ESTIMATES & TREND ANALYSIS

5.1. Application Segment Dashboard
5.2. U.S. Interventional Cardiology and Peripheral Market: Application Movement Analysis
5.3. U.S. Interventional Cardiology and Peripheral Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Angioplasty
  5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Congenital Heart Defect Correction
  5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Thrombectomy
  5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Valvuloplasty
  5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Percutaneous Valve Repair
  5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Others
  5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)

CHAPTER 6. COMPETITIVE LANDSCAPE

6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Vendor Landscape
  6.3.1. Key company heat map analysis, 2024
6.4. Company Profiles
  6.4.1. B. Braun SE
    6.4.1.1. Company overview
    6.4.1.2. Financial performance
    6.4.1.3. Product benchmarking
    6.4.1.4. Strategic initiatives
  6.4.2. BD
    6.4.2.1. Company overview
    6.4.2.2. Financial performance
    6.4.2.3. Product benchmarking
    6.4.2.4. Strategic initiatives
  6.4.3. Cardinal Health
    6.4.3.1. Company overview
    6.4.3.2. Financial performance
    6.4.3.3. Product benchmarking
    6.4.3.4. Strategic initiatives
  6.4.4. Medtronic
    6.4.4.1. Company overview
    6.4.4.2. Financial performance
    6.4.4.3. Product benchmarking
    6.4.4.4. Strategic initiatives
  6.4.5. Teleflex Incorporated
    6.4.5.1. Company overview
    6.4.5.2. Financial performance
    6.4.5.3. Product benchmarking
    6.4.5.4. Strategic initiatives
  6.4.6. W. L. Gore & Associates Inc.
    6.4.6.1. Company overview
    6.4.6.2. Financial performance
    6.4.6.3. Product benchmarking
    6.4.6.4. Strategic initiatives
  6.4.7. Cook
    6.4.7.1. Company overview
    6.4.7.2. Financial performance
    6.4.7.3. Product benchmarking
    6.4.7.4. Strategic initiatives
  6.4.8. Boston Scientific Corporation
    6.4.8.1. Company overview
    6.4.8.2. Financial performance
    6.4.8.3. Product benchmarking
    6.4.8.4. Strategic initiatives
  6.4.9. AngioDynamics
    6.4.9.1. Company overview
    6.4.9.2. Financial performance
    6.4.9.3. Product benchmarking
    6.4.9.4. Strategic initiatives
  6.4.10. Abbott
    6.4.10.1. Company overview
    6.4.10.2. Financial performance
    6.4.10.3. Product benchmarking
    6.4.10.4. Strategic initiatives
  6.4.11. OrbusNeich Medical Group Holdings Limited
    6.4.11.1. Company overview
    6.4.11.2. Financial performance
    6.4.11.3. Product benchmarking
    6.4.11.4. Strategic initiatives

List Of Tables

LIST OF TABLES

Table 1 List of abbreviations
Table 2 U.S. interventional cardiology and peripheral market, by region, 2018 - 2030 (USD Million)
Table 3 U.S. interventional cardiology and peripheral market, by product, 2018 - 2030 (USD Million)
Table 4 U.S. interventional cardiology and peripheral market, by application, 2018 - 2030 (USD Million)

List Of Figures

LIST OF FIGURES

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 U.S. interventional cardiology and peripheral market: market outlook
Fig. 10 U.S. interventional cardiology and peripheral competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 U.S. interventional cardiology and peripheral market driver impact
Fig. 16 U.S. interventional cardiology and peripheral market restraint impact
Fig. 17 U.S. interventional cardiology and peripheral market strategic initiatives analysis
Fig. 18 U.S. interventional cardiology and peripheral market: Product movement analysis
Fig. 19 U.S. interventional cardiology and peripheral market: Product outlook and key takeaways
Fig. 20 Interventional catheters estimates and forecast, 2018 - 2030
Fig. 21 Microcatheters estimates and forecast, 2018 - 2030
Fig. 22 Support microcatheters estimates and forecast, 2018 - 2030
Fig. 23 Delivery microcatheters estimates and forecast, 2018 - 2030
Fig. 24 Others estimates and forecast, 2018 - 2030
Fig. 25 Guidewires estimates and forecast, 2018 - 2030
Fig. 26 Peripheral stents estimates and forecast, 2018 - 2030
Fig. 27 Self-expanding estimates and forecast, 2018 - 2030
Fig. 28 Balloon-expandable estimates and forecast, 2018 - 2030
Fig. 29 Drug-eluting stents estimates and forecast, 2018 - 2030
Fig. 30 Coronary stents estimates and forecast, 2018 - 2030
Fig. 31 Bioabsorbable stents estimates and forecast, 2018 - 2030
Fig. 32 Drug eluting stents estimates and forecast, 2018 - 2030
Fig. 33 Bare metal stents estimates and forecast, 2018 - 2030
Fig. 34 PTCA balloon catheters estimates and forecast, 2018 - 2030
Fig. 35 Atherectomy devices estimates and forecast, 2018 - 2030
Fig. 36 Chronic total occlusion devices estimates and forecast, 2018 - 2030
Fig. 37 Synthetic surgical grafts estimates and forecast, 2018 - 2030
Fig. 38 Embolic protection devices estimates and forecast, 2018 - 2030
Fig. 39 IVC filters estimates and forecast, 2018 - 2030
Fig. 40 PTA balloon catheters estimates and forecast, 2018 - 2030
Fig. 41 Thrombectomy devices estimates and forecast, 2018 - 2030
Fig. 42 U.S. interventional cardiology and peripheral market: Application movement analysis
Fig. 43 U.S. interventional cardiology and peripheral market: Application outlook and key takeaways
Fig. 44 Angioplasty estimates and forecast, 2018 - 2030
Fig. 45 Congenital heart defect correction estimates and forecast, 2018 - 2030
Fig. 46 Thrombectomy estimates and forecast, 2018 - 2030
Fig. 47 Valvuloplasty estimates and forecast, 2018 - 2030
Fig. 48 Percutaneous valve repair estimates and forecast, 2018 - 2030
Fig. 49 Others estimates and forecast, 2018 - 2030